Primary hepatocytes have been used in drug development for the evaluation of hepatotoxicity of candidate compounds. The rapid depression of their hepatic characters in vitro, however, must be improved to predict toxicity with higher accuracy. We have hypothesized that a well-organized tissue construct that includes non-parenchymal cells and appropriate scaffold material(s) could overcome this difficulty by remediating the viability and physiological function of primary hepatocytes. In this study, we constructed an in vitro liver tissue model, consisting of mouse primary hepatocytes assembling around an endothelial cell network on EHS gel, and examined its response to acetaminophen treatment. The increase in lactate dehydrogenase release after the exposure to acetaminophen was induced earlier in the liver tissue model than in monolayer hepatocytes alone, suggesting that the tissue model was more sensitive to an acetaminophen-induced toxicity. On the basis of our results, we conclude that liver tissue models of this kind may enhance the responses of hepatocytes against xenobiotics via the maintenance of hepatic genes and functions such as cytochrome P450s. These findings will contribute to the development of more accurate systems for evaluating hepatotoxicity.
Introduction
Despite the dramatic and evolutional progress made in life sciences over the last decade, the productivity of pharmaceutical companies in bringing new drugs to the market has not been improved (Kola and Landis, 2004; Paul et al., 2010) . Nonetheless, R&D expenditure has been increasing, and the high rate of candidate attrition during development has been a considerable problem. To address these issues, a great deal of effort has been devoted toward reducing the candidate attrition in the late stages of drug development, as well as toward producing new drugs more cost-effectively (Gleeson et al., 2011; Kwong et al., 2011) . It is important to predict and/or detect the toxicity of the drug candidates as early as possible during the process of drug development.
The liver is a multi-functional organ involved in the metabolism, detoxification and excretion of substances. Therefore, compound-induced hepatotoxicity is a major issue in drug discovery and development (Jaeschke et al., 2002; Kaplowitz, 2005) . Although many in vitro trials have used primary cultured hepatocytes prepared from the liver, these cells pose several problems for in vitro hepatotoxicity assays. When cultured by themselves, hepatocytes cannot continue to grow or maintain their specific functions in vitro. The liver is composed of not only parenchymal hepatocytes but also non-parenchymal cells, such as sinusoidal endothelial cells, Kupffer cells, etc. Hepatocytes can express their specific functions only in the structural environment of hepatic tissue. In order to make it possible for primary hepatocytes to survive for long periods and maintain their specific functions in vitro, it is important to maintain cell−cell interactions, both between hepatocytes and between hepatocytes and non-parenchymal cells (Bhatia et al., 1998; Bhatia et al.,1999; Kidambi et al., 2009; Strain, 1999) , as well as proper extracellular matrix (Kleinman et al., 2003; Takashi et al., 2007) .
In this context, we have focused on the interaction between hepatocytes and endothelial cells. In 2005, we successfully achieved hepatic organogenesis from murine embryonic stem (ES) cells (Ogawa et al., 2005; Tsutui et al., 2006) . This mouse ES cell−derived in vitro liver tissue model, IVL mES , included both hepatocyte layers and a sinusoid vascular network; the model was capable of recapitulating most hepatic functions. Due to imperfect control of the hepatic regions in IVL mES , it was difficult to quantitatively evaluate metabolites in this system. Recently, however, Nahmias et al. reported a culture system, 'liver-like tissue'
that included fewer components (Nahmias et al., 2006) . Their system consists of two types of cells, primary hepatocytes and an endothelial cell network that formed vascular structures.
As with IVL mES , liver-like tissue exhibited long-term expression of hepatic genes such as albumin. It would be reasonable to expect that an optimized liver-like tissue would be a useful system for evaluating the hepatotoxic potential of candidate drug compounds.
In this study, we used both mouse primary hepatocytes and human umbilical vein endothelial cells (HUVECs), a representative type of endothelial cells, to construct an in vitro liver model, IVL, for use in drug screening. Using these two types of cells allowed us to specifically examine the expression of hepatic genes, and resulted in development of a simple, cost-effective system. Next, we investigated the response of IVL to xenobiotic treatment in order to assess the utility of this system in the evaluation of hepatotoxicity.
Animals
Male, 6-to 10-week old BALB/cAJc1 mice were purchased from CLEA Japan Inc.
(Tokyo, Japan) and were treated in accordance with local institutional guidelines for the care and use of laboratory animals. DsRed2 transgenic mice carrying the expression vector of DsRed2 fluorescence protein gene, controlled by the CAG promoter, were originally obtained via a DsRed2-expressing ES cell-contributing chimera mouse produced by the aggregation chimera method. The F1 offspring expressing DsRed2 protein has been backcrossed with BALB/cAJcl mice finally to 20 generations. DsRed2 BALB/cAJcl transgenic mouse (male, 6-week old) were used in this study for DsRed2 fluorescent assay. The animal protocol was approved by the Animal Experimentation Committees of Tokyo Institute of Technology.
Preparation of cell culture substrate
Gelatin-coated surfaces were prepared by incubation with heat-sterilized 0.05% gelatin solution for 3 hours at 4°C. Thawing EHS gel was poured into ice-cold 6-well plates (500 μ l/wells), and incubated for 30 min at 37°C to allow polymerization. Laminin, fibronectin, poly-D-lysine, collagen type I and collagen type IV (50 μ g of protein/well) were coated onto surfaces according to the manufacturer's instructions.
Cell culture
HUVECs were maintained in complete EGM-2 (EBM-2 with instructed supplementations as follows; 2% (v/v) FBS, hydrocortisone, hFGF-β, VEGF, R3-IGF-1,
ascorbic acid, hEGF, GA-1000 and heparin) at 37ºC in a humidified atmosphere of 5% CO 2 in air. The cell passage was limited within 10 times. Isolated hepatocytes were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 100 U/mL penicillin and 100 µg/mL streptomycin at 37ºC in a humidified atmosphere of 5% CO 2 in air.
Isolation of primary hepatocytes from mouse liver
Hepatocytes were prepared from mice anesthetized with pentobarbital by an in situ 2-step collagenase perfusion method (Seglen, 1976) , with slight modifications. In brief, after the cannulation of isolated portal vein with a 24-gauge catheter (TERUMO, Tokyo, Japan), mouse liver was pre-perfused in situ with Hank's Buffered Salt Solution (HBSS)
containing EGTA (0.19 g/L) and glucose (0.98 g/L) to remove the blood; next, the liver was perfused with 0.015% collagenase in HBSS. After the extraction of the liver, the cells were dispersed in ice-cold HBSS (pH 7.2) by blade mincing. The cells obtained were filtered through a 100-µm pore mesh nylon cell strainer (BD Biosciences, Bedford, MA, USA) and centrifuged twice for 2 min at 500×g to remove non-parenchymal cells. Subsequently, for further purification, the remaining cells were centrifuged for 2 min at 1200×g, and then subjected to 40% Percoll density gradient centrifugation for 10 min at 1200×g. At this stage, cell viability measured by the trypan blue method was >85%. The isolated hepatocytes were plated at a cell density of 1.0×10 6 cells per well in 6-well plates; cells were grown in DMEM containing 10% (v/v) heat-inactivated FBS, 100 U/mL penicillin and 100 µg/mL streptomycin at 37°C in a humidified incubator with 5% CO 2 /95% air. The medium for cell attachment
was replaced with fresh medium after the first 4 hours of incubation. One day later, the growth medium was exchanged with serum-free medium, and replaced daily thereafter.
Detection of mRNA by RT-PCR
Total RNA was isolated using the acid guanidinium−phenol−chloroform method according to a standard protocol described in elsewhere. The purity and concentrations of isolated RNA were assessed by absorbance determination, and the integrity of the RNA was verified by 0.6% agarose gel electrophoresis in TAE buffer. First strand cDNA was prepared from the extracted total RNA in a reverse transcriptase reaction, using the SuperScript ™ II
Reverse Transcriptase kit and oligo dT primer (Invitrogen) according to the manufacturer's instruction. The cDNA from mRNA of the genes of interest were amplified by PCR in a GeneAmp PCR System 9700 thermal cycler (Applied Biosystems, Foster City, CA) with a set of specific primers (Table 1 and 2). After the PCR, the resulting amplicons were separated by 1.5% (w/v) agarose gel electrophoresis with TBE buffer and detected with ethidium bromide under UV light.
Urea assay
Culture medium collected in each measurement periods was centrifuged for 5 min at 300×g to remove floating cells, and supernatant was stored at −80°C until determination of urea levels. Urea was detected in culture medium using a QuantiChrom ™ Urea Assay Kit 
LDH assay
After incubation for the indicated periods, the culture medium was collected and centrifuged for 5 min at 300×g, and the supernatant was used for determination of LDH level in the culture medium. To detect the LDH levels in whole-cell lysate, the remaining cells were treated with 10 mM phosphate buffer (pH.7.4) containing 1% (w/v) Triton X-100. The cell suspension sample containing the dissolved scaffold materials was homogenized by
passage through a 27-gauge needle, and then centrifuged for 10 min at 800×g at 4°C. The resulting supernatant fraction (whole-cell lysate) was transferred to a new tube. LDH levels in each fraction (culture medium and whole-cell lysate) were detected using SPOTCHEM ™ EZ SP-4430 and SPOTCHEM ™ II LDH (ARKRAY, Kyoto, Japan). Media-released LDH ratio (%) was calculated using the following formula.
Media-released LDH ratio (%) = LDH media /(LDH media + LDH whole-cell lysate ) × 100
Fluorescence intensity assay
In order to count the amount of living hepatocytes quantitatively, DsRed2 fluorescence intensity was measured 24 h after the seeding of red-hepatocytes isolated from the DsRed transgenic mouse. The DsRed2-fluorescence derived from the living red fluorescent hepatocytes attaching on the culture surface was measured by using LAS-4000 system (Fuji film, Tokyo, Japan). Obtained images were analyzed by Multi Gauge program version 3.1 (Fuji film, Tokyo, Japan).
Testosterone Metabolism Assay
To examine the enzymatic activities of Cytochrome P450s, each metabolite of testosterone in the culture medium was quantitatively detected using high performance liquid chromatography (HPLC) as described previously (Tsutui et al., 2006) with some modification.
In brief, testosterone and its metabolites were separated using an HPLC system (LC-10AD VP, Shimadzu, Kyoto, Japan) equipped with a reversed-phase C18 column (Cadenza CD-C18, 10 Afterwards, 80% solvent B was maintained for 30 min. The elution flow throughout was kept constant at a rate of 0.5 mL/min, and testosterones were detected by UV absorbance at 254 nm. The resulting chromatograms were analyzed using the LC Solutions software (Shimadzu). The peak of each metabolite was compared with that of the internal standard in order to determine its quantity. To obtain the standard chromatogram, 2α-OHT, 6β-OHT, 7α-OHT, 11α-HP, 16α-OHT and 16β-OHT were subjected to independent analyses.
CE-TOFMS analysis
3-(N-acetyl-L-cystein-S-yl)acetaminophen, one of the APAP metabolites, was detected using the CE-TOFMS method as described previously (Soga et al., 2006) . In brief, after the 5% mannitol treatment, cells on the EHS gel were saturated with 1 mL of MeOH containing hours when grown on laminin, fibronectin, poly-D-lysine, collagen type I or collagen type IV, as well as on gelatin-coated or non-coated tissue culture 6-well plates. However, on EHS gel, HUVECs rapidly elongated and generated a network structure (Fig. 1A) . After the seeding of HUVECs (3.5×10 5 cell/well in 6-well plates), network morphogenesis on EHS gel was accomplished within a few hours, and could be maintained for at least 4 days (Fig. 1B) .
Subsequently, to compare the maintenance of endothelial cell character of HUVECs on each scaffold material, we measured the expression of endothelial cell−specific marker genes, such as platelet endothelial cell adhesion molecule-1 (PECAM-1) and Von Willebrand factor (vWF) (Fig. 1C) . In HUVECs cultured on EHS gel, expression of these genes was maintained at a high level compared to cells grown on other scaffold materials. It is noteworthy that hepatocyte growth factor (HGF) was strongly expressed in HUVECs only on EHS gel (Fig.   1C ).
On this network structure of HUVECs, freshly isolated mouse primary hepatocytes (1.0×10 6 cell/well in 6-well plates) were seeded and cultured. The primary hepatocytes
migrated toward the HUVEC network and piled next to one another within 24 hours, forming a structure that resembled hepatic tissue ( Fig. 1D and E) . This structure could be maintained for 5 days, at least untill the disruption of HUVEC network. In the absence of a HUVEC network, primary hepatocytes seeded on EHS gel almost never aggregated with each other. The presence of HUVEC on gelatin did not affect the cobblestone morphology of hepatocytes (Fig. 1D) . According to the scheme described in Fig. 1F , this in vitro liver tissue model on EHS gel, which we term IVL EHS , was used in the following experiments.
To confirm if there was no difference in the percentage of attachment of hepatocytes on between gelatin and EHS gel, we used red-fluorescent hepatocytes from the liver of DsRed2 transgenic mouse. Based on the linear relationship between the signal intensity of DsRed2 fluorescence and the total amount of red-hepatocytes (Fig. 1G) , the number of hepatocytes finally attaching on the surface of each culture conditions was almost the same (Fig. 1H) .
The IVL EHS could maintain its hepatic function for a longer period than monolayer culture of hepatocytes
To compare the effect of the IVL EHS to general primary hepatocyte culture on gelatin, we investigated the level of urea production, a major hepatic function (Fig. 2) . After the first 24 hours, urea production did not differ between samples, regardless of whether primary hepatocytes were co-cultured with HUVECs or whether they were grown on gelatin or EHS gel; however, urea levels in the culture was lower when the cells were grown on EHS gel than on gelatin ( Fig. 2A) . The urea level in the culture medium of the HUVEC network alone
was too low (< several hundred μ g/dL) to recognize a significant effect (data not shown). To estimate the ratio of decrease in relative urea levels on EHS gel ( Fig. 2A) , identical volumes (2.0 mL) of urea-containing pre-cultured medium were incubated on gelatin and EHS gel.
As shown in Fig. 2B , a decrease in the urea level was observed on EHS gel in the absence of primary hepatocytes, suggesting that ~30% of the urea was absorbed by the EHS gel. The urea productivity of hepatocytes was not affected by the type of scaffold material or the existence of HUVECs ( Fig. 2A and B) .
In order to investigate whether IVL EHS is superior to other models with regard to the maintenance of liver-specific functions, we examined the time-dependent change of urea productivity during the period when the HUVEC network was adequately maintained. In the case of monolayer culture on gelatin, the urea productivity of hepatocytes rapidly decreased each day (Fig. 2C) . In contrast, culture on EHS gel made the cells comparatively resistant to this decrease (Fig. 2D) . Although the presence of HUVECs did not enhance the potential urea productivity of hepatocytes, EHS gel was superior to gelatin with respect to the maintenance of hepatic functions.
To investigate any possible change in the hepatic gene expression, hepatocytes were cultured in each condition with or without HUVECs for 24 hours, and subjected to RT-PCR analysis. IVL EHS also retained some cytochrome P450 expression at least, as well as monolayer cultured hepatocytes (Fig. 2E) , suggesting that the hepatic potential of IVL EHS was not lower than that of monolayer cultured hepatocytes.
Measurement of in vitro hepatotoxicity induced by acetaminophen treatment
We next examined the hepatotoxicity in the liver tissue model induced by acetaminophen (APAP); this treatment was intended to simulate an exogenous stimulus triggered by xenobiotic treatment. At first, in order to evaluate the effect of APAP on the cytotoxicity of hepatocytes, we incubated hepatocytes on gelatin with APAP at different concentrations for 36
hours. Hepatocytes viability was measured by the WST-1 assay. Since 10 mM APAP was sufficient to induce hepatocyte death within 36 hours (Fig. 3A) , we chose 10 mM of APAP as the direct toxicant concentration for the following experiments. The release of lactate dehydrogenase (LDH) into the cultured medium was measured at various time points.
Differences between APAP-treated and untreated samples started to be observed 24 hours after the addition of APAP (Fig. 3B) . After 36 hours exposure to APAP, LDH level in the culture medium of treated cells was significantly higher than in the control (Fig. 3B) .
Microscopic observation indicates that the monolayer-cultured hepatocytes were lethally injured, and that the normal cytoplasmic projections of spreading hepatocytes, present in control culture on gelatin, were disrupted (Fig. 3C) . The hepatocytes cultured on EHS gel were also injured. The architecture of the liver tissue model, with hepatocytes massing around the HUVEC network, maintained its appearance (Fig. 3C) . It is noteworthy that exposure to APAP for 36 hours did not affect the final levels of LDH in any culture condition, but did affect the time-dependent increase of LDH (Fig. 3D) .
Enhancement of the response to acetaminophen in the IVL EHS
To further investigate whether the construction of the IVL EHS enhances the responsiveness of hepatocytes to APAP, we examined the media-released LDH ratio. As described in Fig. 4A , IVL EHS showed an early response to acetaminophen. 12 hours after the APAP treatment, the ratio of released LDH in the liver tissue model was already higher than in any controls (Fig. 4B) . At this time point, APAP was not directly toxic to HUVEC alone.
Hepatocytes alone on EHS gel were also affected by APAP-dependent toxicity after 24 hours (Fig. 4C) . On the other hand, at those time points, there was no significant difference in the ratio of released LDH caused by APAP treatment in hepatocytes cultured alone on gelatin.
( Fig. 4B and C) . Furthermore, total LDH levels in hepatocytes incubated with APAP for 24 hours were not affected by the type of scaffold material (gelatin or EHS gel) or the presence of HUVECs (Fig. 4D) . In this study, the existence of HUVECs had little effect on the LDH level in the culture medium (under the detectable limitation) and whole cell lysate fraction (Fig. 4E) . Under these experimental conditions, HUVECs produced far less LDH than hepatocytes; thus, the increase of LDH release in IVL EHS under the APAP condition appeared to result from the rise of APAP cytotoxicity in hepatocytes. These results suggest that culture on EHS gel could prevent the depression of responsiveness in hepatocytes that is with other conditions (Fig. 4F) . Furthermore, 3-(N-acetyl-L-cystein-S-yl)acetaminophen, mercapturate, one of the APAP metabolites produced via NAPQI, was quantified by CE-TOFMS in the IVL EHS and primary hepatocyte culture on EHS gel at least 12 h after the APAP treatment. As shown in Table 3 , the amount of mercapturate in the IVL EHS was almost the same as in the primary hepatocyte culture.
Activities of cytochrome P450 isozymes in the IVL EHS
The key mechanism underlying APAP hepatotoxicity is cytochrome P450 mediated NAPQI formation (David 2005) . To quantify the P450 activities as major drug metabolizing enzyme activities in IVL EHS , we quantitatively examined the amount of hydroxylated testosterones in cultured medium. Each P450 enzyme participates independently in the regioselective hydroxylation of testosterone, enabling us to simultaneously investigate the activities of multiple P450s. Testosterone was added into the IVL EHS system, and its metabolites were analyzed by HPLC in their hydroxylated forms. As described in Fig. 5A , retention times of the analytes were as follows: 6β-OHT, 16.3 min; 7α-OHT, 16.9 min; 16α-OHT, 21.3 min; 16β-OHT, 23.9 min; and 2α-OHT, 26.4 min. These products (6β-OHT; 7α-OHT; 16α-OHT; 16β-OHT; 2α-OHT) were differentially converted by specific cytochrome P450s (Cyp3a; Cyp2a4/5 and 2d9; Cyp2d9 and 2b; Cyp2c29 and 2e; Cyp2d)
respectively. The metabolite profile indicates that activities of P450 isozymes in IVL EHS were higher than under other conditions (Fig. 5B) .
Discussion

Positive effect of the construction of IVL EHS
In this study, we showed that culture of hepatocytes in a model that resembles the structure of hepatic tissue is superior to monolayer culture of primary hepatocytes, both in regard to the maintenance of some hepatic genes and the response to xenobiotics, at least in the case of APAP. These findings suggest that this system could be applied to the evaluation of compound-associated hepatotoxicity. Since primary hepatocytes have a more complete set of phase I and II metabolizing enzymes than immortalized cell lines, they have been used to develop assay systems that are more representative of in vivo hepatocytes (Dambach et al., 2005) . A monolayer system consisting of confluent culture of freshly isolated hepatocytes is already a well-established model that provides a better assessment of the metabolic effects and potential hepatotoxicity of interesting compounds (Hewitt et al., 2007; Kikkawa et al., 2006) . However, this widely used model has some limitations: low proliferative capacity (not exceeding a few days), loss of liver-specific functions such as drug metabolizing enzymes, and so on. These phenotypic changes reportedly occur early during the isolation process and after seeding, probably as a result of their adaptation to microenvironmental alterations (Guillouzo, 1998) . Therefore, we aimed to construct a sophisticated culture condition that mimics the situation in the liver, and examine its utility.
We succeeded in developing a structure that resembles hepatic tissue on EHS gel (Fig. 1) .
It is well known that the EHS gel induce rapid formation of a capillary-like tubular network of endothelial cells, and can preserve hepatocyte functions such as albumin production,
important role in the preservation and modulation of hepatocyte phenotypes in vitro, as well as in vivo (Bhatia et al., 1999) . As we described in Results, the hepatocytes in our in vitro liver tissue model were able to benefit from all three groups of factors: HGF, EHS gel and hepatocyte−HUVEC interaction correspond respectively to cytokines, ECM and heterotypic interactions. Although the specific molecular mechanisms involved in the hepatocyte recruitment process needs to be elucidated, our results suggest the importance of the non-parenchymal cell population for the ex vivo recapitulation of the in vivo liver environment.
Further study will shed light on these molecular mechanism(s) and the development of more suitable biomaterials for the construction of in vitro liver tissue models.
Application of IVL EHS to hepatotoxicity studies
At present, accumulating evidence suggests that the presence of non-parenchymal cells As shown in Fig. 2 , the initial capability of hepatocytes to produce urea depends very little on the culture conditions. However, culture on EHS gel more efficiently preserved hepatic function than culture on gelatin. Under conditions of low external stress, the positive effect of EHS gel is so large that it is difficult to determine the exact contribution of co-cultivation with endothelial cells, at least in short-term culture. On the other hand, the construction of a structure resembling hepatic tissue reinforced the responsiveness of hepatocytes to acetaminophen treatment (Figs. 3 and 4) .
Acetaminophen is a commonly used analgesic/antipyretic drug, and its overdose induces liver injury in humans and experimental animals. This model hepatotoxicant is converted by a cytochrome P450 enzyme into its reactive metabolite form, N-acetyl-p-benzoquinone imine (NAPQI). In particular, CYP2E1, 1A2, 3A4 and 2A6 play major roles in this oxidation process (James et al., 2003) . At therapeutic doses of acetaminophen, the reactive metabolite is efficiency detoxified by glutathione (GSH) conjugation. However, at a toxic dose, GSH is depleted by this conjugation, and the excess metabolite covalently binds to protein, resulting in the induction of oxidative stress and the development of toxicity (Jaeschke et al., 2003; James et al., 2003; Reid et al., 2005) .
According to in vivo experiments and clinical evidence, these events occur within a few hours after the administration of a toxic dose of acetaminophen. Furthermore, previous studies have indicated that the response of parenchymal cells to acetaminophen might be amplified by contributions from non-parenchymal cells such as liver sinusoidal endothelial cells and Kupffer cells (DeLeve et al., 1997; Holt et al., 2010; Ito et al., 2003) . The toxicity
observed in vitro monolayer culture models, however, occurs much later than in vivo toxicity.
With regard to these concerns, the liver tissue model includes several improvements that better mimic the in vivo situation. In fact, our results suggest that the response of hepatocytes to APAP-toxicity was reinforced in our liver tissue model, IVL EHS , probably via the maintenance of expression, or up-regulation, of cytochromes such as Cyp2e1. It is noteworthy that the activities of drug metabolizing enzymes were higher in IVL EHS than under other conditions (Fig. 5) .
So far, there have been no reports of the direct detection of NAPQI in hepatocytes, particularly in hepatocytes cultured on EHS gel. However, in this study, to confirm the functional metabolism of APAP in IVL EHS , its cellular extract was assayed for mercapturate by CE-TOFMS (Table 3) . This mercapturate form is produced metabolically from APAP via NAPQI (Soga et al., 2006) . Since the NAPQI-dependent cytotoxicity is caused after the saturation of detoxification capability, intracellular administration of mercapturate suggests that IVL EHS maintains a higher (or at least equivalent) metabolizing capacity than monocultures on EHS gel.
Conclusions and future perspective
In summary, this study revealed the superiority of liver tissue models over the monolayer culture of hepatocytes. In short-term culture, EHS gel effectively maintained hepatic function; the further introduction of endothelial cells contributed to an early response to hepatotoxicant that mirrors the kinetics of the response in vivo. These results suggest that
IVL EHS is suitable for use as a compound-associated hepatotoxicity system, and is superior to existing in vitro monolayer systems (Fig. 6) . Importantly, we performed the minimum modification necessary to archive the hepatic tissue-like structure. Many ingenious attempts have been made to mimic the in vivo liver architecture and developed improved systems for evaluating hepatotoxicity, e.g., micro-patterning (El-Ali et al., 2006; Khetani and Bhatia, 2008) , shear stress (Vinci et al., 2011) , Cyp-inducers such as phenobarbital, and so on.
Incorporation of these technologies will contribute to the further improvement of our strategy. (E) Expression levels of hepatic genes. Adult liver, mouse adult liver at 8 weeks of age;
Hepatocytes, hepatocytes immediately after isolation; hprt, internal loading control. hours incubation with 10 mM APAP in each culture condition. Data are expressed as the means ± S.D. n = 3-9. *, P < 0.05; **, P < 0.01; ***, P < 0.001, relative to the APAP-absent control; †, P < 0.05; † †, P < 0.01 relative to the HUVEC-absent control; NS, not significant. Adult liver, mouse adult liver at 8 weeks of age; hprt, internal loading control. 
